Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.77 0.09 +0.77%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a

Neogen Corporation (NEOG) Current ratio

Alert me on Current ratio

Neogen Corporation's current ratio at the end of the quarter to 31 August 2026 was 3.9×, up 0.1× from fiscal 2026 (3.8×). Over the past ten years it has ranged from 3.3× (fiscal 2025) to 11.8× (fiscal 2019); the current reading is higher than 25% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2026 3.8× 15.27%
FY2025 3.3× (13.17%)
FY2024 3.8× (5.20%)
FY2023 4.0× (49.98%)
FY2022 8.1× (27.03%)
FY2021 11.0× (0.44%)
FY2020 11.1× (5.69%)
FY2019 11.8× 20.99%
FY2018 9.7× 19.37%
FY2017 8.1× (6.25%)

Quarterly newest first

Period Current ratio Change
Aug 2026 3.9× 1.95%
May 2026 3.8× (2.45%)
Feb 2026 3.9× 0.26%
Nov 2025 3.9× 9.01%
43 more quarters

Against its own ten years

Low 3.3× High 11.8×
Ten-year median 8.4×
Current reading's percentile 25

Current ratio against peers

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on NEOG